• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查起始年龄前新发糖尿病患者的结直肠癌发病风险更高。

Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation.

机构信息

Dept. of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.

GROW - School for Oncology and Developmental Biology, Maastricht, The Netherlands.

出版信息

Sci Rep. 2017 Apr 24;7:46527. doi: 10.1038/srep46527.

DOI:10.1038/srep46527
PMID:28436468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5402260/
Abstract

Type 2 diabetes mellitus (T2DM) is associated with greater risk for colorectal cancer (CRC). The age of onset of T2DM is decreasing worldwide. An increased CRC risk in young T2DM patients could be relevant for the age at which to initiate CRC screening. We report on CRC risk in T2DM patients with attention to age of diagnosis. We used pharmacy data (from 1998 to 2010) from the PHARMO Database Network linked to the Eindhoven Cancer Registry. Multivariable time-dependent Cox regression analyses were conducted to calculate hazard ratios (HR) for developing CRC comparing T2DM with non-T2DM. During 2,599,925 years of follow-up, 394 CRC cases among 41,716 diabetes patients (mean age 64.0 yr, 48% men) and 1,939 CRC cases among 325,054 non-diabetic patients (mean age 51.2 yr, 46% men) were identified. Diabetes was associated with an increased CRC risk in both men and women (HR 1.3, 95% CI 1.2-1.5), particularly in the first 6 months after T2DM diagnosis and pronounced in the proximal colon. This risk was even higher in men younger than 55 years (HR 2.0, 95% CI 1.0-3.8). T2DM was associated with a time-varying and subsite-specific increased CRC risk, which was even higher in men aged <55 years.

摘要

2 型糖尿病(T2DM)与结直肠癌(CRC)风险增加相关。T2DM 的发病年龄在全球范围内呈下降趋势。年轻 T2DM 患者 CRC 风险增加可能与开始 CRC 筛查的年龄有关。我们报告了 T2DM 患者的 CRC 风险,并特别关注诊断时的年龄。我们使用了 PHARMO 数据库网络的药房数据(1998 年至 2010 年),并与埃因霍温癌症登记处相关联。使用多变量时依 Cox 回归分析计算比较 T2DM 与非 T2DM 发生 CRC 的风险比(HR)。在 2599925 年的随访期间,在 41716 名糖尿病患者(平均年龄 64.0 岁,48%为男性)中发现了 394 例 CRC 病例,在 325054 名非糖尿病患者(平均年龄 51.2 岁,46%为男性)中发现了 1939 例 CRC 病例。糖尿病与男性和女性的 CRC 风险增加相关(HR 1.3,95%CI 1.2-1.5),尤其是在 T2DM 诊断后的前 6 个月,且在近端结肠中更为明显。在年龄小于 55 岁的男性中,这种风险更高(HR 2.0,95%CI 1.0-3.8)。T2DM 与时间变化和部位特异性的 CRC 风险增加相关,在年龄<55 岁的男性中风险更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6869/5402260/c3de9b757adf/srep46527-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6869/5402260/c3de9b757adf/srep46527-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6869/5402260/c3de9b757adf/srep46527-f1.jpg

相似文献

1
Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation.结直肠癌筛查起始年龄前新发糖尿病患者的结直肠癌发病风险更高。
Sci Rep. 2017 Apr 24;7:46527. doi: 10.1038/srep46527.
2
Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.2型糖尿病与男性和女性特定亚部位结直肠癌风险:荷兰饮食与癌症队列研究结果
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):896-903. doi: 10.1097/MEG.0000000000000626.
3
Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.糖尿病、胰岛素样生长因子通路中的遗传变异与结直肠癌风险。
Int J Cancer. 2019 Oct 1;145(7):1774-1781. doi: 10.1002/ijc.32365. Epub 2019 May 6.
4
Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.糖尿病和胰岛素使用对结直肠癌诊断后生存的影响:癌症预防研究-II 营养队列。
J Clin Oncol. 2012 Jan 1;30(1):53-9. doi: 10.1200/JCO.2011.38.0303. Epub 2011 Nov 28.
5
Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China.2型糖尿病与结直肠癌风险增加相关:来自一项国际生态学研究及中国基于人群的风险分析的证据
Public Health. 2009 Aug;123(8):540-4. doi: 10.1016/j.puhe.2009.06.019. Epub 2009 Aug 6.
6
Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.胰岛素增强,二甲双胍降低 2 型糖尿病患者结直肠癌风险。
QJM. 2020 Mar 1;113(3):194-200. doi: 10.1093/qjmed/hcz253.
7
Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database.基于国家癌症数据库的早发性结直肠癌患者生存分析。
JAMA Netw Open. 2021 Jun 1;4(6):e2112539. doi: 10.1001/jamanetworkopen.2021.12539.
8
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.爱荷华州女性健康研究中的糖尿病与特定亚部位结直肠癌风险
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):133-7.
9
Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.2型糖尿病患者结直肠癌风险的性别和部位特异性差异。
Int J Colorectal Dis. 2019 Feb;34(2):269-276. doi: 10.1007/s00384-018-3191-7. Epub 2018 Nov 12.
10
New onset of type 2 diabetes after colorectal cancer diagnosis: Results from three prospective US cohort studies, systematic review, and meta-analysis.结直肠癌诊断后新发 2 型糖尿病:来自三项前瞻性美国队列研究、系统评价和荟萃分析的结果。
EBioMedicine. 2022 Dec;86:104345. doi: 10.1016/j.ebiom.2022.104345. Epub 2022 Nov 11.

引用本文的文献

1
Downregulation of the Unfolded Protein Response Links Metformin Treatment to Good Clinical Outcomes in Colorectal Cancer Patients.未折叠蛋白反应的下调将二甲双胍治疗与结直肠癌患者良好的临床结局联系起来。
Curr Oncol. 2025 Feb 27;32(3):138. doi: 10.3390/curroncol32030138.
2
Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy.2型糖尿病患者降糖治疗后CA19-9水平变化及相关影响因素
Sci Rep. 2025 Jan 8;15(1):1264. doi: 10.1038/s41598-025-85807-4.
3
Associations between Diabetes Mellitus and Selected Cancers.

本文引用的文献

1
Prevalence and incidence of diabetes mellitus: a nationwide population-based pharmaco-epidemiological study in Sweden.糖尿病的患病率和发病率:瑞典一项基于全国人口的药物流行病学研究
Diabet Med. 2015 Oct;32(10):1319-28. doi: 10.1111/dme.12716. Epub 2015 Feb 20.
2
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.2 型糖尿病与癌症:观察性研究荟萃分析的伞状评价。
BMJ. 2015 Jan 2;350:g7607. doi: 10.1136/bmj.g7607.
3
Colorectal cancer.结直肠癌。
糖尿病与某些癌症之间的关联。
Int J Mol Sci. 2024 Jul 8;25(13):7476. doi: 10.3390/ijms25137476.
4
Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1).匈牙利初发2型糖尿病患者的新发癌症风险(第1部分)
Cancers (Basel). 2024 Apr 29;16(9):1745. doi: 10.3390/cancers16091745.
5
Geographic Variation and Risk Factor Association of Early Versus Late Onset Colorectal Cancer.早发性与晚发性结直肠癌的地理差异及危险因素关联
Cancers (Basel). 2023 Feb 4;15(4):1006. doi: 10.3390/cancers15041006.
6
Bcl-2 and p53 immunophenotypes in colorectal adenocarcinoma in type 2 diabetes mellitus versus non-diabetic patients.2 型糖尿病与非糖尿病患者结直肠腺癌中 Bcl-2 和 p53 的免疫表型。
Rom J Morphol Embryol. 2022 Jul-Sep;63(3):521-528. doi: 10.47162/RJME.63.3.06.
7
Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents.某些新型喹唑啉酮类作为抗结直肠癌药物的生物学评价、分子对接分析及ADME特性研究
ACS Omega. 2022 May 23;7(22):18443-18458. doi: 10.1021/acsomega.2c00812. eCollection 2022 Jun 7.
8
Diabetes and Risks of Right-Sided and Left-Sided Colon Cancer: A Meta-Analysis of Prospective Cohorts.糖尿病与右半结肠癌和左半结肠癌风险:前瞻性队列的荟萃分析
Front Oncol. 2022 Apr 7;12:737330. doi: 10.3389/fonc.2022.737330. eCollection 2022.
9
Hyperglycemia alters N-glycans on colon cancer cells through increased production of activated monosaccharides.高血糖通过增加激活的单糖的产生来改变结肠癌细胞上的 N-聚糖。
Glycoconj J. 2022 Oct;39(5):663-675. doi: 10.1007/s10719-022-10057-9. Epub 2022 Apr 5.
10
Host-microbiome protein-protein interactions capture disease-relevant pathways.宿主-微生物组蛋白质-蛋白质相互作用捕获与疾病相关的途径。
Genome Biol. 2022 Mar 4;23(1):72. doi: 10.1186/s13059-022-02643-9.
Lancet. 2014 Apr 26;383(9927):1490-1502. doi: 10.1016/S0140-6736(13)61649-9. Epub 2013 Nov 11.
4
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.有利于糖尿病患者癌症起始和进展的临床和分子机制。
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):808-15. doi: 10.1016/j.numecd.2013.05.006. Epub 2013 Aug 7.
5
Metformin and the risk of cancer: time-related biases in observational studies.二甲双胍与癌症风险:观察性研究中的时间相关性偏倚。
Diabetes Care. 2012 Dec;35(12):2665-73. doi: 10.2337/dc12-0788.
6
Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.糖尿病与癌症 2:糖尿病药物的作用和共同危险因素的影响。
Cancer Causes Control. 2012 Jul;23(7):991-1008. doi: 10.1007/s10552-012-9971-4. Epub 2012 Apr 25.
7
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.2 型糖尿病发病后癌症发病率的时变:潜在检测偏倚的证据。
Diabetologia. 2011 Sep;54(9):2263-71. doi: 10.1007/s00125-011-2242-1. Epub 2011 Jul 12.
8
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.2 型糖尿病发病率增加,二甲双胍降低台湾人群结直肠癌、肝癌和胰腺癌发病率:一项 80 万人代表性人群前瞻性队列研究。
BMC Cancer. 2011 Jan 18;11:20. doi: 10.1186/1471-2407-11-20.
9
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.阿司匹林和 NSAIDs 对结直肠癌风险和生存的影响。
Gut. 2010 Dec;59(12):1670-9. doi: 10.1136/gut.2009.203000. Epub 2010 Sep 15.
10
Epidemiology of type 1 diabetes.1 型糖尿病的流行病学。
Endocrinol Metab Clin North Am. 2010 Sep;39(3):481-97. doi: 10.1016/j.ecl.2010.05.011.